Want to join the conversation?
$MNK's net sales for FY15 jumped 60.8% from last year. This increase was primarily on inclusion of sales from Acthar, Ofirmev and Inomax. Specialty Generics sales increased due to higher sales of hydrocodone-related products and inclusion of full year of sales from BioVectra, partially offset by decreased sales of Methylphenidate ER.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?